ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/07/2026
Voltar para busca
Dado oficial do USPTO
LIPOSUC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
02/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
30/11/2021
Data de registro
29/10/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/10/2024
Última transação
02/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
FR
Examinador
ANGOTTI, SALVATORE JOHN
Unidade examinadora
L80
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
BIOFAR
Representantes
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products for enhancing energy production; anti-viral pharmaceutical preparations for enhancing energy production; medicines for enhancing energy production; pharmaceutical preparations for the treatment of the flu; cough pastilles for pharmaceutical and medical purposes; cough syrup; pharmaceutical productsparapharmaceutical products and food supplements for medical and paramedical use which may contain proteinscarbohydrateslipids and fibersmicronutrients such as vitamins and mineralsamino acids and fatty acidsin the form of individual doses such as capsuleseffervescent tablets and notsugared almondsgelatin capsulessachetschewing gumdry extracts and powders for pharmaceutical and parapharmaceutical usegranulesmicro-spherescellulose impregnated with active substancesdepuratives for enhancing energy production; pharmaceutical products made with plantsplant extracts and vegetable extracts in effervescent and other formsgranules; parapharmaceutical preparationsplant-based food supplementsplant extracts and vegetable extracts in effervescent and other forms; parapharmaceutical products used for medical purposesbased on plantsplant extractsvegetable extracts in effervescent and other forms; pharmaceutical and parapharmaceutical preparations containing minerals and vitamins in effervescent and other forms; minerals and vitamin supplements in effervescent and other forms; pharmaceutical products for phytotherapy; nutritional supplements for the nutrient intake in a normal diet; all dietetic substances adapted for medical use; nutritional supplements for medical and pharmaceutical use ready for human consumption based on food ingredients of plant and mineral origin; strengthening food substances for medical purposes; medicinal herbs; dietetic sugar for medical use; dietetic beverages adapted for medical use; medicated confectionery; food and nutritional supplements for non-medical use and meal replacements for non-medical useall these goods being made with meatmeat extractsfishpoultrygamefruit and vegetables; nutritional supplements for paramedical use as additions to the nutrient intake in a normal dietall for paramedical usedietetic substancesnutritional supplements for paramedical use prepared for human consumption based on foodstuffs of vegetable and mineral originfor strengtheningparamedical useall for paramedical use which may contain proteinscarbohydrateslipids and fibersmicronutrients such as vitamins and mineralsamino acids and fatty acidsin the form of individual doses such as capsuleseffervescent tablets and notsugared almondsgelatin capsulessachetschewing gumdry extracts and powders for pharmaceutical and parapharmaceutical usegranulesmicro-spherescellulose impregnated with active substancesdepuratives for enhancing energy production; Dietetic and dietary goodsmeal replacementsprepared meals nutritional and herbal supplementsfruitvegetablesfish and meat other than for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/04/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
30/03/2025
FIMP
FINAL DISPOSITION PROCESSED
30/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/01/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
29/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/08/2024
PUBO
PUBLISHED FOR OPPOSITION
13/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/05/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
29/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/02/2024
GNRT
NON-FINAL ACTION E-MAILED
21/02/2024
CNRT
NON-FINAL ACTION WRITTEN
21/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/07/2023
GNRT
NON-FINAL ACTION E-MAILED
11/07/2023
CNRT
NON-FINAL ACTION WRITTEN
11/07/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
18/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/05/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/05/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/05/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/05/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/05/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/05/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/05/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/05/2023
RFNT
REFUSAL PROCESSED BY IB
11/12/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/11/2022
RFRR
REFUSAL PROCESSED BY MPU
21/11/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/09/2022
CNRT
NON-FINAL ACTION WRITTEN
19/09/2022
DOCK
ASSIGNED TO EXAMINER
09/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
18/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/01/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/01/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
30/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIPOSUC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.